Exploring the mechanism of luteolin improving immune and inflammatory responses in systemic sclerosis based on systems biology and cell experiments
Authors:
- 6 July 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 138, 112587
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Sesquiterpenoids Isolated from the Rhizomes of Genus AtractylodesChemistry & Biodiversity, 2022
- Understanding the phytochemistry and molecular insights to the pharmacology of Angelica archangelica L. (garden angelica) and its bioactive componentsPhytotherapy Research, 2021
- Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathologyActa Neuropathologica, 2021
- Powerful anti‐inflammatory action of luteolin: Potential increase with IL‐38BioFactors, 2021
- Analytical determinations of luteolinBioFactors, 2021
- Phytochemistry and cardiovascular protective effects of Huang‐Qi (Astragali Radix)Medicinal Research Reviews, 2021
- Data Mining Study on Prescription Patterns of Different Dosage Forms of Chinese Herbal Medicines for Treating and Improving Immune-Inflammatory Indices in Patients with Rheumatoid ArthritisChinese Journal of Integrative Medicine, 2020
- The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic reviewAutoimmunity Reviews, 2017
- Social/economic costs and health-related quality of life in patients with scleroderma in EuropeThe European Journal of Health Economics, 2016
- A bibliometric study of earthquake research: 1900–2010Scientometrics, 2012